Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OraSure’s Over-The-Counter HIV Test Could Begin Trials This Summer

This article was originally published in The Gray Sheet

Executive Summary

OraSure Technologies expects to launch clinical studies for an over-the-counter indication for its OraQuick Advance rapid HIV test this summer, according to CEO Douglas Michels
Advertisement

Related Content

Chembio Joins The Race For Over-The-Counter HIV Test
Chembio Joins The Race For Over-The-Counter HIV Test
OraSure Still Hopeful For Government Purchases Of Rapid HIV Tests In 2006
OraSure Still Hopeful For Government Purchases Of Rapid HIV Tests In 2006
OraQuick distribution
OraQuick distribution
FDA Panel Mulls Clinical Studies, Labeling For Over-The-Counter HIV Tests
FDA Panel Mulls Clinical Studies, Labeling For Over-The-Counter HIV Tests
Advertisement
UsernamePublicRestriction

Register

MT023343

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel